Perfil
Anne-Laure Autret-Cornet currently works at OSE Immunotherapeutics SA, as Director & Chief Administrative Officer from 2025.
Ms. Autret-Cornet also formerly worked at Deloitte SAS, as Auditor and Effimune SA, as Manager-Financial & Administrative from 2013 to 2016.
Ms. Autret-Cornet received her undergraduate degree from Ecole Supérieure De Commerce D'angers.
Cargos activos de Anne-Laure Autret-Cornet
| Empresas | Cargo | Inicio |
|---|---|---|
| OSE IMMUNOTHERAPEUTICS | Director Administrativo | 01/05/2016 |
Antiguos cargos conocidos de Anne-Laure Autret-Cornet.
| Empresas | Cargo | Fin |
|---|---|---|
Effimune SA
Effimune SA BiotechnologyHealth Technology Engages in the research and development of drugs for transplantation and immune-mediated diseases | Director Financiero/CFO | 01/01/2016 |
Deloitte SAS
Deloitte SAS Miscellaneous Commercial ServicesCommercial Services Provides accounting, tax, consulting, financial advisory and legal services | Corporate Officer/Principal | - |
Formación de Anne-Laure Autret-Cornet.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 4 |
|---|---|
Deloitte SAS
Deloitte SAS Miscellaneous Commercial ServicesCommercial Services Provides accounting, tax, consulting, financial advisory and legal services | Commercial Services |
Ecole Supérieure De Commerce D'angers
Ecole Supérieure De Commerce D'angers Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Effimune SA
Effimune SA BiotechnologyHealth Technology Engages in the research and development of drugs for transplantation and immune-mediated diseases | Health Technology |
OSE Immunotherapeutics SA
OSE Immunotherapeutics SA Pharmaceuticals: MajorHealth Technology Develops immunotherapy products for late-stage cancers | Health Technology |
- Bolsa de valores
- Insiders
- Anne-Laure Autret-Cornet
















